A large randomized clinical trial published in JACC demonstrates that baduanjin — an 800-year-old Chinese qigong practice comprising eight structured movements—can lower blood pressure comparably to brisk walking. In 216 adults aged ≥40 years with stage-1 hypertension (systolic 130–139 mm Hg), five weekly 10–15-minute sessions produced sustained reductions of approximately 3 mm Hg in 24-hour systolic blood pressure and 5 mm Hg in office readings at both 12 and 52 weeks, without requiring equipment, gym access, or ongoing supervision. The intervention combined aerobic, flexibility, isometric, and mindfulness elements and proved safe, with adherence and blood-pressure effects similar to brisk walking yet easier to maintain long-term in community settings.

For Indian clinicians managing rising hypertension prevalence, these findings are relevant because baduanjin is low-cost, culturally adaptable, and scalable across urban and rural populations where conventional exercise infrastructure is limited. The study’s multicenter design and one-year follow-up support its potential integration into lifestyle counseling alongside pharmacotherapy, particularly for patients who struggle with sustained adherence to higher-intensity regimens.